Note 9 – Subsequent Events 

The Company has analyzed its operations subsequent to June 30, 2019 and noted the following subsequent events:

On July 1, 2019 the Company closed an underwritten public offering in which it sold 6,666,667 shares of the Company’s common stock at a public offering price of $3.00 per share. In connection with the closing of the offering, the Company received net proceeds of $18,150 after deducting underwriting discounts and commissions of $1,400 and other offering expenses of approximately $450. In addition, the Company granted the representative of the several underwriters in the offering (the “Representative”) a 30-day option (the “Over-Allotment Option”) to purchase up to an aggregate 1,000,000 additional shares of the Company’s common stock at an exercise price of $3.00 per share. 

On July 4, 2019, the Company exercised its option to extend the lease for its office in Israel for an additional thirty-six months, ending the lease term on December 31, 2022. The terms of the lease remain unchanged. 

On July 10, 2019, the Company closed the sale of an additional 648,333 shares of its common stock at a price of $3.00 per share, pursuant to the partial exercise of the Over-Allotment Option. In connection with the closing of the partial exercise of the Over-Allotment Option, the Company received additional net proceeds of $1,809 after deducting underwriting discounts and commissions of $136. 

On August 1, 2019, the Company entered into a consulting agreement whereby it agreed to issue warrants to purchase 20,000 shares of common stock of the Company. The warrants will vest over a one-year period on a quarterly basis and are exercisable at the closing share price on August 8, 2019 on the Nasdaq Capital Market, and expire three years from the date of issuance. 

On August 8, 2019, the Company’s Compensation Committee approved the issuance of 45,000 options to employees which vest over a three-year period on a quarterly basis to purchase shares of the Company’s common stock with an exercise price equal to the closing share price [on August 8, 2019 on the Nasdaq Capital Market.] 

On August 8, 2019, the Company's Compensation Committee approved the issuance of 125,000 options to be granted to employees on September 3, 2019 which vest over a three-year period on a quarterly basis to purchase shares of the Company's common stock with an exercise price equal to the closing share price on September 3, 2019 on the Nasdaq Capital Market.